抗腫瘤藥/ Cultural corridor
當前位置： 首頁 > 九洲產品 > 中間體 > 抗腫瘤藥
| 排序 | 產品名稱 | CAS號 | 用途 |
|---|---|---|---|
| 901-1 | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-氨基嘧啶 N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine |
152460-10-1 | Imatinib intermediate |
| 901-2 | 4-((4-甲基哌嗪-1-烷基)甲基)苯甲酰氯 4-((4-methylpiperazin-1-yl)methyl)benzoyl chloride |
148077-69-4 | Imatinib intermediate |
| 902-1 | 4-(3-氯-4-氟苯氨基)-7-甲氧基喹唑啉-6-醇 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol |
184475-71-6 | Gefitinib intermediate |
| 902-2 | N-(3-氯丙基)嗎啉 N-(3-Chloropropyl)morpholine |
7357-67-7 | Gefitinib intermediate |
| 903-1 | 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
179688-29-0 | Erlotinib intermediate |
| 903-2 | 4-chloro-6,7-di(2-methoxyethoxy)quinazoline |
183322-18-1 | Erlotinib intermediate |
| 903-4 | 3-氨基苯乙炔 3-Aminophenylacetylene |
54060-30-9 | Erlotinib intermediate |
| 904-1 | 4-(4-氨基苯氧基)-N-甲基-2-吡啶甲酰胺 4-(4-Aminophenoxy)-N-methylpicolinamide |
284462-37-9 | Sorafenib intermediate |
| 904-2 | 5-氨基-2-氯三氟甲苯 5-Amino-2-chlorobenzotrifluoride |
320-98-4 | Sorafenib intermediate |
| 905-1 | 4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 | Nilotinib intermediate |
| 905-2 | 3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
641571-11-1 | Nilotinib intermediate |
| 906-1 | N-(2-(二乙基氨基)乙基)-5-甲?；?2,4-二甲基-1H-吡咯-3-甲酰胺 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide |
356068-86-5 | Sunitinib intermediate |
| 906-2 | 5-氟-1,3-二氫吲哚-2-酮 5-Fluoro-1,3-dihydro-indol-2-one |
56341-41-4 | Sunitinib intermediate |
| 907-1 | N-(2-氯-6-甲基苯基)-2-[(6-氯-2-甲基-4-嘧啶基)氨基]-5-噻唑甲酰胺 N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide |
302964-08-5 | Dasatinib intermediate |
| 907-2 | N-羥乙基哌嗪 N-(2-Hydroxyethyl)piperazine |
103-76-4 | Dasatinib intermediate |
| 908-1 | 3-氯-4-(3-氟-芐氧基)-苯胺 3-Chloro-4-(3-fluoro-benzyloxy)-phenylamine |
202197-26-0 | Lapatinib intermediate |
| 908-2 | 5-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉]-2-呋喃甲醛 5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde |
231278-84-5 | Lapatinib intermediate |
說明：上述產品僅在無專利保護的區域或在相關專利已到期的國家或區域生產或銷售。
總共有 17 篇記錄 這是第 1 頁
浙公網安備 33100202000816號